• Air Traffic Control
  • Govt Finance Report
  • Pension Reform
  • Events
  • Reason facebook
  • Reason twitter
  • Reason youtube
Reason Foundation
  • About
    • About Us
    • Contact Us
    • Email Newsletters
    • Events
    • FAQs
    • Jobs & Internships
    • Savas Award
    • Shop
    • Staff
    • Trustees & Officers
  • Experts

      Browse Our Experts

      • Aaron Smith
        Director of Education Reform
      • Adrian Moore
        Vice President of Policy
      • Baruch Feigenbaum
        Senior Managing Director, Transportation Policy
      • Geoff Lawrence
        Research Director
      • Guy Bentley
        Director of Consumer Freedom
      • Leonard Gilroy
        Vice President of Government Reform
      • Robert Poole
        Director of Transportation Policy
      • Vittorio Nastasi
        Director of Criminal Justice Policy
      • View All Experts
  • Topics

      Browse Our Topics

      • Air Traffic Control
      • Annual Highway Report
      • Consumer Freedom
      • Criminal Justice Reform
      • Drug Policy
      • Education
      • Gov’t Financial Transparency
      • Pension Reform
      • Technology
      • Transportation
      • Urban Growth and Land Use
      • View All Topics
  • Publications
    • Latest
    • Government Financial Project
    • Annual Highway Report
    • Annual Pension Report
    • Annual Privatization Report
    • Aviation Newsletter
    • Backgrounders
    • Commentaries
    • Data Visualization
    • Education Newsletter
    • Email Newsletters
    • Pension Reform Newsletter
    • Policy Studies
    • Psychedelics Newsletter
    • Public Schools Without Boundaries
    • Testimony
    • Transportation Newsletter
    • Amicus Briefs
  • Reason.com
  • Donate
    • Donate Online
    • Donate Crypto
    • Ways To Give
    • Torchbearer Society
    • Planned Giving

Topics › Drug Policy › Ibogaine

Ibogaine


  • Arizona joins Texas in ibogaine clinical trial research push for veteran, first responder mental health
    Arizona joins Texas in ibogaine clinical trial research push for veteran, first responder mental health

    Commentary by Leonard Gilroy

  • Psychedelics Policy Newsletter: FDA prioritizes drug reform for psychedelics, Texas advances ibogaine research, and more
    Psychedelics Policy Newsletter: FDA prioritizes drug reform for psychedelics, Texas advances ibogaine research, and more

    Psychedelics Policy Newsletter by Gregory Ferenstein

  • State psychedelics legalization and policy roundup — June 2025
    State psychedelics legalization and policy roundup — June 2025

    Commentary by Gregory Ferenstein

  • Texas Senate Bill 2308 could advance ibogaine as a treatment for opioid use disorder
    Texas Senate Bill 2308 could advance ibogaine as a treatment for opioid use disorder

    Testimony by Madison Carlino

  • Psychedelics Policy Newsletter: Reforms for Congress, data for rescheduling, and more
    Psychedelics Policy Newsletter: Reforms for Congress, data for rescheduling, and more

    Psychedelics Policy Newsletter by Gregory Ferenstein

  • State psychedelics legalization and policy roundup — April 2025
    State psychedelics legalization and policy roundup — April 2025

    Commentary by Gregory Ferenstein

  • Nevada Assembly Bill 378 could help patients access psychedelic therapies
    Nevada Assembly Bill 378 could help patients access psychedelic therapies

    Testimony by Madison Carlino

  • Legislative approaches that could improve access to psychedelic-based medicine
    Legislative approaches that could improve access to psychedelic-based medicine

    Testimony by Geoffrey Lawrence, Leonard Gilroy and Gregory Ferenstein

  • RFK Jr.’s opioid crisis plan
    RFK Jr.’s opioid crisis plan

    Commentary by Layal Bou Harfouch

More Ibogaine

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Follow

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS

Email Updates

Get weekly updates from Reason.

This field is for validation purposes and should be left unchanged.

More About Reason Foundation

  • About
  • Contact
  • Donate
  • Email Newsletters
  • Events
  • Jobs and Internships
  • Policy Research
  • Reason magazine
  • Shop

Contact

Reason Foundation
5737 Mesmer Ave.
Los Angeles, CA 90230
(310) 391-2245

1630 Connecticut Ave NW
Suite 600
Washington, DC 20009
(202) 986-0916

Privacy Policy
Accessibility

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
Copyright © 2026 Reason Foundation